IP Library Granted Patent US 12,559,710
Granted Patent B2
US 12,559,710 · App. 19/091,700 · Granted Feb 24, 2026

Liquid level and flow rate detection within a cell processing system

Inventors: Vladimir Azersky (San Jose, CA); David Freiberger (San Francisco, CA); Caitlin A. Regan (San Mateo, CA); Wilson Wai Toy (San Francisco, CA); Matthias Weber (South San Francisco, CA); Yiming Xu (San Mateo, CA)
Assignee: Cellares Corporation
C12M41/48C12M23/44C12M41/44G01F23/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,559,710
App. No.
19/091,700
Granted
Feb 24, 2026
Kind
B2
Abstract

The present disclosure relates to systems and methods for monitoring liquid levels within cartridges of automated cell processing systems during cell processing. A method for automated cell processing may first include coupling a cell processing cartridge to an instrument configured to perform a cell processing operation with at least one module of the cartridge. Next, the method may include detecting, via a vision system of the instrument, a liquid level of a liquid within one or more cell processing modules of the cartridge. Finally, the method may include determining a volume of the liquid based on the liquid level.

Claims (34)

1 . A method for calibrating an automated cell processing system, comprising:

coupling a calibration cartridge to an instrument within the automated cell processing system, wherein the instrument comprises a vision system and the calibration cartridge comprises one or more fiducial markers;

detecting a location of each of the one or more fiducial markers using the vision system; and

generating a calibration result for one or more modules of the calibration cartridge using the locations of each of the one or more fiducial markers, wherein the one or more modules of the calibration cartridge correspond to one or more modules of a cell processing cartridge configured to interface with the instrument to perform a cell processing operation.

2 . The method of claim 1 , wherein generating the calibration result comprises:

determining a region of interest (ROI) defined by the locations of each of the one or more fiducial markers; and

mapping the ROI onto a reference image.

3 . The method of claim 1 , wherein the calibration result comprises an alignment map defining alignment between the vision system of the instrument and the one or more fiducial markers of the calibration cartridge.

4 . The method of claim 3 further comprising applying the alignment map to an output of each of one or more sensors of the vision system during an automated cell processing procedure.

5 . The method of claim 4 , wherein the output comprises one or more images of the calibration cartridge obtained by the vision system.

6 . The method of claim 1 , wherein the one or more modules comprises one or more of a bioreactor module, a magnetic cell separation (MCS) module, a centrifugal counterflow elutriation module, and a waste module.

7 . The method of claim 6 , wherein the bioreactor module comprises a bioreactor compartment, a mixing compartment, and one or more thermal compartments.

8 . The method of claim 6 , wherein the calibration result comprises a first calibration result and the one or more modules comprise the MCS module, the method further comprising:

detecting one or more features of the MCS module of the calibration cartridge using the vision system;

generating an MCS module map based on the one or more features that defines alignment between an actual position of the calibration cartridge and a desired position of the calibration cartridge; and

applying the MCS module map to an output of the vision system during a cell processing procedure to align the vision system to the MCS module.

9 . The method of claim 1 , wherein each of the one or more modules comprises at least one fluid compartment configured to store a liquid therein.

10 . The method of claim 1 further comprising coupling the cell processing cartridge to the instrument, wherein one or more cameras of the vision system are directed toward the one or more modules of the cell processing cartridge when the cell processing cartridge is coupled to the instrument.

11 . The method of claim 1 , wherein the calibration result comprises a first calibration result, the method further comprising:

detecting coordinates of a calibration image having a known dimension using the vision system; and

generating a second calibration result using the coordinates of the calibration image.

12 . The method of claim 11 , wherein generating the second calibration result comprises mapping an output of the vision system to the coordinates of the calibration image.

13 . The method of claim 12 , wherein the second calibration result comprises a distortion map defining distortion of the calibration image from the coordinates of the output of the vision system.

14 . The method of claim 13 further comprising applying the distortion map to the output of each of one or more sensors of the vision system during an automated cell processing procedure to compensate for the distortion.

15 . The method of claim 12 , wherein the output comprises a real-time image.

16 . The method of claim 11 further comprising:

combining the first and second calibration results into a combined calibration result; and

applying the combined calibration result to an output of the vision system during a cell processing procedure.

17 . The method of claim 1 , wherein the vision system comprises a plurality of cameras supported by the instrument.

18 . The method of claim 17 , wherein one or more of the plurality of cameras comprises a lens having a focal length of between about 8 mm and about 18 mm.

19 . The method of claim 17 , wherein one or more of the plurality of cameras comprises a lens having a focal length of between about 35 mm and about 50 mm.

20 . The method of claim 1 , wherein the automated cell processing system is calibrated during initial setup of the system.

21 . The method of claim 1 , wherein the instrument comprises a bioprocessing instrument or a sterile liquid transfer instrument.

22 . The method of claim 1 , wherein the calibration result is used to compensate for one or more of misalignment between the vision system and the calibration cartridge or distortion from the vision system.

Assignments (2)
SECURITY INTEREST Recorded May 5, 2026
From: CELLARES CORPORATION
To: TRINITY CAPITAL INC.
Reel/Frame 075545/0558 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2025
From: AZERSKY, VLADIMIR; FREIBERGER, DAVID; REGAN, CAITLIN A.; TOY, WILSON WAI; WEBER, MATTHIAS; XU, YIMING
To: CELLARES CORPORATION
Reel/Frame 072171/0794 →
Continuity (2)
Provisional Application 63570739 · Mar 27, 2024
Related Publication 20250304904A1 · Oct 2, 2025
References Cited (303)
US 3728227A · Elson et al. · 1973 [cited by applicant]
US 4234023A · Sogi et al. · 1980 [cited by applicant]
US 4696902A · Bisconte · 1987 [cited by applicant]
US 4839292A · Cremonese · 1989 [cited by applicant]
US 4911833A · Schoendorfer et al. · 1990 [cited by applicant]
US 5058619A · Zheng · 1991 [cited by applicant]
US 5656491A · Cassani et al. · 1997 [cited by applicant]
US 6102678A · Peclat · 2000 [cited by applicant]
US 6267559B1 · Mossman et al. · 2001 [cited by applicant]
US 6649419B1 · Anderson · 2003 [cited by applicant]
US 7550287B2 · Hibino et al. · 2009 [cited by applicant]
US 7745209B2 · Martin et al. · 2010 [cited by applicant]
US 7816128B2 · Nakashima et al. · 2010 [cited by applicant]
US 8158426B2 · Wilson et al. · 2012 [cited by applicant]
US 8158427B2 · Wilson et al. · 2012 [cited by applicant]
US 8168432B2 · Wilson et al. · 2012 [cited by applicant]
US 8273572B2 · Martin et al. · 2012 [cited by applicant]
US 8415144B2 · Wilson et al. · 2013 [cited by applicant]
US 8440458B2 · Zijlstra et al. · 2013 [cited by applicant]
US 8470589B2 · Martin et al. · 2013 [cited by applicant]
US 8492140B2 · Smith et al. · 2013 [cited by applicant]
US 8546142B2 · Martin et al. · 2013 [cited by applicant]
US 8697443B2 · Wilson et al. · 2014 [cited by applicant]
US 8727132B2 · Miltenyi et al. · 2014 [cited by applicant]
US 8809044B2 · Wilson · 2014 [cited by applicant]
US 8846399B2 · Martin et al. · 2014 [cited by applicant]
US 8956860B2 · Vera et al. · 2015 [cited by applicant]
US 9040290B2 · Martin et al. · 2015 [cited by applicant]
US 9045721B2 · Martin et al. · 2015 [cited by applicant]
US 9080149B2 · Bosio et al. · 2015 [cited by applicant]
US 9255243B2 · Wilson et al. · 2016 [cited by applicant]
US 9279099B2 · Okano et al. · 2016 [cited by applicant]
US 9290730B2 · Martin et al. · 2016 [cited by applicant]
US 9410114B2 · Wilson et al. · 2016 [cited by applicant]
US 9441192B2 · Wilson et al. · 2016 [cited by applicant]
US 9499780B2 · Smith et al. · 2016 [cited by applicant]
US 9534195B2 · Smith et al. · 2017 [cited by applicant]
US 9556485B2 · Lin et al. · 2017 [cited by applicant]
US 9567565B2 · Vera et al. · 2017 [cited by applicant]
US 9597355B2 · Magnant · 2017 [cited by applicant]
US 9625463B2 · Miltenyi et al. · 2017 [cited by applicant]
US 9701932B2 · Smith et al. · 2017 [cited by applicant]
US 9732317B2 · Wilson · 2017 [cited by applicant]
US 9783768B2 · Larcher et al. · 2017 [cited by applicant]
US 9845451B2 · Martin et al. · 2017 [cited by applicant]
US 10047342B2 · Eibl et al. · 2018 [cited by applicant]
US 10053663B2 · Kabaha et al. · 2018 [cited by applicant]
US 10119970B2 · Miltenyi et al. · 2018 [cited by applicant]
US 10131876B2 · Kaiser et al. · 2018 [cited by applicant]
US 10253316B2 · Masquelier et al. · 2019 [cited by applicant]
US 10294658B2 · Scannon et al. · 2019 [cited by applicant]
US 10323258B2 · Bernate et al. · 2019 [cited by applicant]
US 10329559B1 · Masquelier et al. · 2019 [cited by applicant]
US 10385307B2 · Rowley et al. · 2019 [cited by applicant]
US 10421959B1 · Masquelier et al. · 2019 [cited by applicant]
US 10508288B1 · Bernate et al. · 2019 [cited by applicant]
US 10519437B1 · Masquelier et al. · 2019 [cited by applicant]
US 10533156B2 · Vera et al. · 2020 [cited by applicant]
US 10584333B1 · Masquelier et al. · 2020 [cited by applicant]
US 10584334B1 · Masquelier et al. · 2020 [cited by applicant]
US 10588994B2 · Kawamura et al. · 2020 [cited by applicant]
US 10620212B2 · Miltenyi et al. · 2020 [cited by applicant]
US 10689669B1 · Feldman et al. · 2020 [cited by applicant]
US 10705090B2 · Miltenyi et al. · 2020 [cited by applicant]
US 10705091B2 · Miltenyi et al. · 2020 [cited by applicant]
US 10723986B2 · Smith et al. · 2020 [cited by applicant]
US 10724043B2 · Sixto et al. · 2020 [cited by applicant]
US 10844338B1 · Smith et al. · 2020 [cited by applicant]
US 11161111B2 · Kabaha et al. · 2021 [cited by applicant]
US 11198845B2 · Parietti et al. · 2021 [cited by applicant]
US 11371018B2 · Shi et al. · 2022 [cited by applicant]
US 11376587B2 · Thakkar et al. · 2022 [cited by applicant]
US 11447745B2 · Shi et al. · 2022 [cited by applicant]
US 11701654B2 · Azersky et al. · 2023 [cited by applicant]
US 11786896B2 · Thakkar et al. · 2023 [cited by applicant]
US 11826756B2 · Azersky et al. · 2023 [cited by applicant]
US 11872557B2 · Biz et al. · 2024 [cited by applicant]
US 12157119B2 · Gerlinghaus et al. · 2024 [cited by applicant]
US 12180453B2 · Chang et al. · 2024 [cited by applicant]
US 12305156B2 · Burkeen et al. · 2025 [cited by applicant]
US 12337321B2 · Malleo et al. · 2025 [cited by applicant]
US 12350664B2 · Pesch et al. · 2025 [cited by applicant]
US 12350667B2 · Azersky et al. · 2025 [cited by applicant]
US 12350668B2 · Azersky et al. · 2025 [cited by applicant]
US 12399193B2 · Tian et al. · 2025 [cited by applicant]
US 12403468B2 · Azersky et al. · 2025 [cited by applicant]
US 20030030272A1 · Johnson et al. · 2003 [cited by applicant]
US 20050260743A1 · Drake et al. · 2005 [cited by applicant]
US 20060194193A1 · Tsuruta et al. · 2006 [cited by applicant]
US 20060257999A1 · Chang et al. · 2006 [cited by applicant]
US 20070185472A1 · Baumfalk et al. · 2007 [cited by applicant]
US 20080057568A1 · Kan et al. · 2008 [cited by applicant]
US 20080176318A1 · Wilson et al. · 2008 [cited by applicant]
US 20090042281A1 · Chang et al. · 2009 [cited by applicant]
US 20090247417A1 · Haas et al. · 2009 [cited by applicant]
US 20100172045A1 · Goodman · 2010 [cited by examiner]
US 20100301071A1 · Alstad et al. · 2010 [cited by applicant]
US 20110003380A1 · Miltenyi et al. · 2011 [cited by applicant]
US 20120138156A1 · Hofman et al. · 2012 [cited by applicant]
US 20120148415A1 · Brueckner · 2012 [cited by applicant]
US 20130115617A1 · Wilson · 2013 [cited by applicant]
US 20130189120A1 · Nelson et al. · 2013 [cited by applicant]
US 20140309795A1 · Norton et al. · 2014 [cited by applicant]
US 20150307829A1 · Dedry et al. · 2015 [cited by applicant]
US 20160208216A1 · Vera et al. · 2016 [cited by applicant]
US 20160303563A1 · Granier et al. · 2016 [cited by applicant]
US 20160320381A1 · Holmes et al. · 2016 [cited by applicant]
US 20160320422A1 · Fritchie et al. · 2016 [cited by applicant]
US 20170014149A1 · Nakayashiki et al. · 2017 [cited by applicant]
US 20170058527A1 · Williams et al. · 2017 [cited by applicant]
US 20170239420A1 · Wells · 2017 [cited by applicant]
US 20170248697A1 · Lo · 2017 [cited by applicant]
US 20170307502A1 · Mason et al. · 2017 [cited by applicant]
US 20170313977A1 · Wilson · 2017 [cited by applicant]
US 20170321226A1 · Gill et al. · 2017 [cited by applicant]
US 20170362554A1 · Martin et al. · 2017 [cited by applicant]
US 20180031592A1 · Dority · 2018 [cited by applicant]
US 20180051243A1 · Hogan et al. · 2018 [cited by applicant]
US 20180078935A1 · Hung et al. · 2018 [cited by applicant]
US 20180185849A1 · Kaplan et al. · 2018 [cited by applicant]
US 20180196918A1 · Sadowski et al. · 2018 [cited by applicant]
US 20190212233A1 · Jovanovich et al. · 2019 [cited by applicant]
US 20190275519A1 · Castillo et al. · 2019 [cited by applicant]
US 20190292510A1 · Tandon et al. · 2019 [cited by applicant]
US 20190316120A1 · Masquelier et al. · 2019 [cited by applicant]
US 20200009557A1 · Frigard et al. · 2020 [cited by applicant]
US 20200025782A1 · Ahlfors · 2020 [cited by applicant]
US 20200095550A1 · Vera et al. · 2020 [cited by applicant]
US 20200132534A1 · Luedemann · 2020 [cited by applicant]
US 20200159198A1 · Kapre et al. · 2020 [cited by applicant]
US 20200283713A1 · Ball et al. · 2020 [cited by applicant]
US 20200292552A1 · Miltenyi et al. · 2020 [cited by applicant]
US 20200353004A1 · Nowak et al. · 2020 [cited by applicant]
US 20200368411A1 · Camisani et al. · 2020 [cited by applicant]
US 20200406221A1 · Dabrowski et al. · 2020 [cited by applicant]
US 20210032583A1 · Smith et al. · 2021 [cited by applicant]
US 20210035655A1 · Tanouchi et al. · 2021 [cited by applicant]
US 20210047668A1 · Dabrowski et al. · 2021 [cited by applicant]
US 20210079344A1 · Bosio et al. · 2021 [cited by applicant]
US 20210147807A1 · Lickert et al. · 2021 [cited by applicant]
US 20210253997A1 · Wilson · 2021 [cited by applicant]
US 20210269755A1 · Smith et al. · 2021 [cited by applicant]
US 20210283565A1 · Gerlinghaus et al. · 2021 [cited by applicant]
US 20210283606A1 · Thakkar et al. · 2021 [cited by applicant]
US 20210301239A1 · Natsume et al. · 2021 [cited by applicant]
US 20210324318A1 · Parietti et al. · 2021 [cited by applicant]
US 20210354104A1 · Pesch et al. · 2021 [cited by applicant]
US 20220002652A1 · Patrick et al. · 2022 [cited by applicant]
US 20220127558A1 · Sowwan et al. · 2022 [cited by applicant]
US 20220143610A1 · Biz et al. · 2022 [cited by applicant]
US 20220150650A1 · Rucker · 2022 [cited by applicant]
US 20220163438A1 · Klas et al. · 2022 [cited by applicant]
US 20220282199A1 · Vann · 2022 [cited by applicant]
US 20220284574A1 · Wagner · 2022 [cited by examiner]
US 20220325219A1 · Parietti et al. · 2022 [cited by applicant]
US 20220347683A1 · Thakkar et al. · 2022 [cited by applicant]
US 20230044320A1 · Chalony et al. · 2023 [cited by applicant]
US 20230149922A1 · Thakkar et al. · 2023 [cited by applicant]
US 20230159917A1 · Handique et al. · 2023 [cited by applicant]
US 20230321650A1 · Azersky et al. · 2023 [cited by applicant]
US 20230415154A1 · Pesch et al. · 2023 [cited by applicant]
US 20230415155A1 · Biz et al. · 2023 [cited by applicant]
US 20240018955A1 · Hannah et al. · 2024 [cited by applicant]
US 20240165613A1 · Azersky et al. · 2024 [cited by applicant]
US 20240167466A1 · Paraluppi · 2024 [cited by applicant]
US 20240240764A1 · Gabrielli et al. · 2024 [cited by applicant]
US 20240254426A1 · Elpel et al. · 2024 [cited by applicant]
US 20240255537A1 · Malleo et al. · 2024 [cited by applicant]
US 20240279585A1 · Griffin et al. · 2024 [cited by applicant]
US 20240279588A1 · Malleo et al. · 2024 [cited by applicant]
US 20240318116A1 · Chang et al. · 2024 [cited by applicant]
US 20240326043A1 · Gerlinghaus et al. · 2024 [cited by applicant]
US 20240369586A1 · Tian et al. · 2024 [cited by applicant]
US 20240377420A1 · Cesarek · 2024 [cited by applicant]
US 20240390897A1 · Azersky et al. · 2024 [cited by applicant]
US 20240390898A1 · Azersky et al. · 2024 [cited by applicant]
US 20240399365A1 · Biz et al. · 2024 [cited by applicant]
US 20240402206A1 · Boppart et al. · 2024 [cited by applicant]
US 20250002837A1 · Bharat · 2025 [cited by applicant]
US 20250059492A1 · Beban et al. · 2025 [cited by applicant]
US 20250065331A1 · Malleo et al. · 2025 [cited by applicant]
US 20250066708A1 · Burkeen et al. · 2025 [cited by applicant]
US 20250066709A1 · Grout et al. · 2025 [cited by applicant]
US 20250129321A1 · Malleo et al. · 2025 [cited by applicant]
US 20250207076A1 · Marchiando et al. · 2025 [cited by applicant]
US 20250236832A1 · Chang et al. · 2025 [cited by applicant]
US 20250283026A1 · Carmichael et al. · 2025 [cited by applicant]
CN 104203333A · 2014 [cited by applicant]
CN 108660060A · 2018 [cited by applicant]
EP 0246912A2 · 1987 [cited by applicant]
EP 0991389A1 · 2000 [cited by applicant]
EP 0824380B1 · 2002 [cited by applicant]
EP 3134512B1 · 2019 [cited by applicant]
EP 2809449B1 · 2019 [cited by applicant]
EP 3359294B1 · 2020 [cited by applicant]
EP 3928867A1 · 2021 [cited by applicant]
GB 2268187A · 1994 [cited by applicant]
JP 2007325586A · 2007 [cited by applicant]
KR 20130018286A · 2013 [cited by applicant]
WO WO2006102416A2 · 2006 [cited by applicant]
WO WO2006112870A1 · 2006 [cited by applicant]
WO WO2006118282A1 · 2006 [cited by applicant]
WO WO2007139742A1 · 2007 [cited by applicant]
WO WO2009072003A2 · 2009 [cited by applicant]
WO WO2017041051A1 · 2017 [cited by applicant]
WO WO2017123663A1 · 2017 [cited by applicant]
WO WO2018015561A1 · 2018 [cited by applicant]
WO WO2018102471A1 · 2018 [cited by applicant]
WO WO2019232504A2 · 2019 [cited by applicant]
WO WO2020009700A1 · 2020 [cited by applicant]
WO WO2020014264A1 · 2020 [cited by applicant]
WO WO2021168368A1 · 2021 [cited by applicant]
WO WO2021183687A2 · 2021 [cited by applicant]
WO WO2021212124A1 · 2021 [cited by applicant]
WO WO2024112702A1 · 2024 [cited by applicant]
WO WO2024206703A1 · 2024 [cited by applicant]
WO WO2025007051A2 · 2025 [cited by applicant]
WO WO2025038974A1 · 2025 [cited by applicant]
WO WO2025041046A1 · 2025 [cited by applicant]
WO WO2025202944A2 · 2025 [cited by applicant]
Shabalina et al. (“ARTag, AprilTag and CALTag Fiducial Systems Comparison in a Presence of Partial Rotation: Manual and Automated Approaches” in ICINCO (2017) LNEE 495:536-558 92019), Springer Nature Switzerland). [cited by examiner]
ChargePoint (2021). Aseptic split butterfly valve 10-6 sterility assurance, located at https://www.thechargepoint.com/products/aseptic-split-butterfly-valve-10-6-sterility-assurance/, 2 total pages. [cited by applicant]
CPC (2014). “6 traits of non-spill: How quick disconnect couplings evolved for low-pressure fluid handling,” White Paper 8004, 4 total pages. [cited by applicant]
CPC (2014). “How single-use connections advance aseptic processing: Increased process flexibility and reliability, reduced costs,” White Paper 7004, 6 total pages. [cited by applicant]
CPC (2018). Comparison Guide: Tube Welders and Aseptic Connectors, Technical Guide 7009, 3 total pages. [cited by applicant]
EMD Millipore (2015). “Lynx® S2S Connector—Low temperature compatibility (−80 C),” 4 total pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 17/331,554 mailed Aug. 29, 2024, 18 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 18/799,963 mailed Jan. 30, 2025, 10 pages. [cited by applicant]
Final Office Action mailed on Apr. 28, 2022, for U.S. Appl. No. 17/198,134, filed Mar. 10, 2021, 11 pages. [cited by applicant]
Final Office Action mailed on Apr. 28, 2022, for U.S. Appl. No. 17/331,554, filed May 26, 2021, 16 pages. [cited by applicant]
Final Office Action mailed on Jul. 31, 2023, for U.S. Appl. No. 17/331,554, filed May 26, 2021, 19 pages. [cited by applicant]
Final Office Action mailed on Mar. 31, 2023, for U.S. Appl. No. 17/579,478, filed Jan. 19, 2022, 8 pages. [cited by applicant]
Garcia et al., “Microfluidic Screening of Electric Fields for Electroporation” Sci Rep. Feb. 19, 2016; 6:21238. pp. 1-11. [cited by applicant]
Genetic Engineering & Biotechnology News (2006). “Thermal welding for sterile connections,” located at https://www.genengnews.com/magazine/47/thermal-welding-for-sterile-connections/, 5 total pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/IB2024/058105 mailed Dec. 16, 2024, 12 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2024/022079 mailed Sep. 12, 2024, 25 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2024/042795 mailed Dec. 16, 2024, 11 pages. [cited by applicant]
International Search Report mailed on Oct. 13, 2021, for PCT Application No. PCT/US2021/021773, filed on Mar. 10, 2021, 13 pages. [cited by applicant]
Invitation to Pay Additional Fees for International Application No. PCT/US2024/022079 dated Jul. 17, 2024, 19 pages. [cited by applicant]
Jain, S. et al. (2011). “The complete automation of cell culture: improvements for high-throughput and high-content screening,” J. Biomol. Screen 16:932-939. [cited by applicant]
Kato, R. et al. (2010). “A Compact, Automated Cell Culture System for Clinical Scale Cell Expansion from Primary Tissues,” Tissue Engineering: Part C 16:947-956. [cited by applicant]
Kempner, M.E. and Felder, R.A., “A review of cell culture automation”. JALA: Journal of the Association for Laboratory Automation (Apr. 2002); 7(2): 56-62. [cited by applicant]
Kino-Oka, M. et al. (2005). “Bioreactor Design for Successive Culture of Anchorage-Dependent Cells Operated in an Automated Manner,” Tissue Engineering 11:535-545. [cited by applicant]
Knoll, A. et al. (2004). “Flexible automation of cell culture and tissue engineering tasks,” Biotechnol. Prog. 20:1825-1835. [cited by applicant]
Lutkemeyer, D. et al. (2000). “First steps in robot automation of sampling and sample management during cultivation of mammalian cells in pilot scale,” Biotechnol. Prog. 16:822-828. [cited by applicant]
MEDInstill (2021). INTACT™ Connectors, located at https://www.medinstill.com/intactconnectors.php, 1 total page. [cited by applicant]
Millipore® (2020). “Technical Brief—Choosing the right sterile connector based on design and sterility test results,” 4 total pages. [cited by applicant]
Millipore Sigma (2020). “Lynx® CDR Connectors,” Datasheet, 4 total pages. [cited by applicant]
Millipore Sigma (2021). Lynx® CDR Connectors, located at https://www.emdmillipore.com/US/en/product/Lynx-CDR-Connectors,MM_NF-C188801, 2 total pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/244,051 mailed Oct. 9, 2024, 10 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/759,602 mailed Feb. 20, 2025, 15 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/759,602 mailed Nov. 8, 2024, 10 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/792,358 mailed on Nov. 6, 2024, 5 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/799,963 mailed Sep. 30, 2024, 9 pages. [cited by applicant]
Non-Final Office action for U.S. Appl. No. 18/920,607 mailed Feb. 28, 2025, 10 pages. [cited by applicant]
Non-Final Office Action mailed on Apr. 24, 2024, for U.S. Appl. No. 17/331,554, filed May 26, 2021, 17 pages. [cited by applicant]
Non-Final Office Action mailed on Dec. 22, 2022, for U.S. Appl. No. 17/579,478, filed Jan. 19, 2022, 8 pages. [cited by applicant]
Non-Final Office Action mailed on Dec. 3, 2021, for U.S. Appl. No. 17/331,556, filed May 26, 2021, 9 pages. [cited by applicant]
Non-Final Office Action mailed on Feb. 3, 2022, for U.S. Appl. No. 17/198,134, filed Mar. 10, 2021, 5 pages. [cited by applicant]
Non-Final Office Action mailed on Jun. 26, 2023, for U.S. Appl. No. 17/198,134, filed Mar. 10, 2021, 15 pages. [cited by applicant]
Non-Final Office Action mailed on Mar. 16, 2023, for U.S. Appl. No. 17/331,554, filed May 26, 2021, 16 pages. [cited by applicant]
Non-Final Office Action mailed on Oct. 28, 2021, for U.S. Appl. No. 17/331,554, filed May 26, 2021, 11 pages. [cited by applicant]
Non-Final Office Action mailed on Oct. 6, 2021, for U.S. Appl. No. 17/198,134, filed Mar. 10, 2021, 7 pages. [cited by applicant]
Non-Final Office Action mailed on Sep. 13, 2023, for U.S. Appl. No. 18/141,329, filed Apr. 28, 2023, 7 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 17/331,554 mailed Mar. 5, 2025, 8 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/487,884 mailed Feb. 26, 2025, 8 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/792,358 mailed on Mar. 3, 2025, 8 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/792,360 mailed Mar. 4, 2025, 9 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/792,360 mailed on Jan. 29, 2025, 9 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/810,388 mailed Jan. 21, 2025, 8 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/810,388 mailed on Oct. 9, 2024, 9 pages. [cited by applicant]
Notice of Allowance mailed on Apr. 11, 2024, for U.S. Appl. No. 17/198,134, filed Mar. 10, 2021, 9 pages. [cited by applicant]
Notice of Allowance mailed on Jul. 18, 2023, for U.S. Appl. No. 17/849,422, filed Jun. 24, 2022, 8 pages. [cited by applicant]
Notice of Allowance mailed on Jul. 25, 2023, for U.S. Appl. No. 17/579,478, filed Jan. 19, 2022, 8 pages. [cited by applicant]
Notice of Allowance mailed on Jun. 8, 2023, for U.S. Appl. No. 17/849,422, filed Jun. 24, 2022, 8 pages. [cited by applicant]
Notice of Allowance mailed on Mar. 1, 2022, for U.S. Appl. No. 17/331,556, filed May 26, 2021, 8 pages. [cited by applicant]
Notice of Allowance mailed on Mar. 22, 2023, for U.S. Appl. No. 17/992,784, filed Nov. 22, 2022, 8 pages. [cited by applicant]
Notice of Allowance mailed on Oct. 4, 2023, for U.S. Appl. No. 18/141,329, filed Apr. 28, 2023, 8 pages. [cited by applicant]
Pharma Japan, “Astellas Set to Cut Development Time with Cell Culture Robot, Eyes 4 Billion Yen Profit per Product” Aug. 9, 2023, 3 pages. [cited by applicant]
Qu, B. et al., “Droplet Electroporation in Microfluidics for Efficient Cell Transformation with or without Cell Wall Removal,” Lab Chip (2012) 12:4483-4488. [cited by applicant]
Saint Gobain (2017). “Pure-Fit® SC—Secure aseptic connections,” Brochure, 5 total pages. [cited by applicant]
Sartorius Stedim Biotech (2011). “Opta® SFT,” 4 total pages. [cited by applicant]
Schwartz C., “Optimizing Cell Separation with Beckman Coulter's Centrifugal Elutriation System,” Beckmann Coulter Life Sciences (2014) 6 total pages. [cited by applicant]
SeriesLock™ (2021). Features and Specifications, located at https://serieslock.com/, 5 total pages. [cited by applicant]
Shi, Y. et al. (1992). “Performance of Mammalian Cell Culture Bioreactor with a New Impeller Design,” Biotechnology and Bioengineering 40:260-270. [cited by applicant]
Steris (2018). “A compilation of material compatibilities with vaporized hydrogen peroxide,” 2 total pages. [cited by applicant]
Steris (2018). “Sterility assurance levels (SALS): Irradiation,” 3 total pages. [cited by applicant]
Steris (2020). “Overview of sterilization technology comparison,” 1 total page. [cited by applicant]
Strahlendorf, K.A. et al. (2009). “Bio Pharm International—A review of sterile connectors,” vol. 2009 Supplement, Issue 8, located at https://www.biopharminternational.com/view/review-sterile-connectors, 9 total pages. [cited by applicant]
U.S. Appl. No. 18/988,628, filed Dec. 19, 2024, by Marchiando et al. [cited by applicant]
U.S. Appl. No. 29/898,923, filed Aug. 2, 2023, by Gerlinghaus et al. [cited by applicant]
Written Opinion of the International Searching Authority mailed on Oct. 13, 2021, for PCT Application No. PCT/US2021/021773, filed on Mar. 10, 2021, 20 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 18/244,051 mailed Apr. 4, 2025, 11 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 18/759,602 mailed on May 28, 2025, 12 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 18/807,699 mailed on Aug. 20, 2025, 22 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 18/920,607 mailed Jun. 4, 2025, 10 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2024/036245 mailed Jun. 11, 2025, 13 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/807,699 mailed Apr. 29, 2025, 19 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 17/331,554 mailed Apr. 10, 2025, 6 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/487,884 mailed on Apr. 3, 2025, 8 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/799,963 mailed Jul. 1, 2025, 7 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/810,388 mailed Apr. 30, 2025, 5 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 19/075,709 mailed Jul. 29, 2025, 10 pages. [cited by applicant]